Fewer than 1 in 100 patients with chronic hepatitis C get triple therapy

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [41] Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate
    Neuman, MG
    Blendis, LM
    Shear, NH
    Malkiewicz, IM
    Ibrahim, A
    Katz, GG
    Sapir, D
    Halpern, Z
    Brill, S
    Peretz, H
    Magazinik, S
    Konikoff, FM
    CLINICAL BIOCHEMISTRY, 2001, 34 (03) : 183 - 188
  • [42] Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Bruno, Savino
    Craxi, Antonio
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 936 - 942
  • [43] Factors associated with triple therapy discontinuation due to adverse effects among patients with hepatitis C genotype 1 chronic infection
    Miotto, N.
    Pisoni Zanaga, L.
    Sellan, E.
    Goncales, L.
    Mendes, L.
    Lazarini, M.
    Stucchi, R.
    Lopes Goncales, F., Jr.
    Gonzalez Vigani, A.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 27 - 28
  • [44] SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir
    Milazzo, Laura
    Peri, Anna Maria
    Mazzali, Cristina
    Magni, Carlo
    Calvi, Elisa
    De Nicolo, Amedeo
    Clementi, Emilio
    Cheli, Stefania
    D'Avolio, Antonio
    Antinori, Spinello
    Falvella, Felicia Stefania
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) : 1155 - 1160
  • [45] THE COST-EFFECTIVENESS OF TELAPREVIR TRIPLE THERAPY IN TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS IN TURKEY
    Ozdemir, O.
    VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [46] Treatment of chronic hepatitis B/C coinfected patients with consensus interferon/ribavirin/lamivudine triple therapy
    Kaiser, S
    Hass, HG
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [47] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [48] Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients
    Aksoz, S.
    Kaya, S.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 88 - 89
  • [49] Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
    Uyama, Hirokazu
    Nakamura, Hideji
    Hayashi, Eijiro
    Ogawa, Hiroyuki
    Enomoto, Hirayuki
    Yoshida, Kenya
    Okuda, Yorihide
    Yamamoto, Mitsunari
    Hada, Toshikazu
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2007, 37 (05) : 325 - 330
  • [50] Triple therapy in the Hepatitis C virus
    Fernandez Castroagudin, Javier
    Molina Perez, Esther
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (10) : 634 - 634
12345